Joint with: Cardiometabolism in Health and Disease
Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects

Jan 26–29, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Lora K. Heisler, James Trevaskis, Michael A Cowley and Matthias H. Tschöp

  In Person
  On Demand

Jan 26–29, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Lora K. Heisler, James Trevaskis, Michael A Cowley and Matthias H. Tschöp

Supported by the  Directors' Fund
Important Deadlines
Early Registration Deadline: Nov. 24, 2025
Scholarship Deadline: Sep. 24, 2025
Short Talk Abstract Deadline: Sep. 24, 2025
Poster Abstract Deadline: Jan. 5, 2026
Meeting Summary

# Drug Discovery, Bioengineering and Digital
# Metabolism and Cardiovascular

Obesity, a leading cause of human morbidity and mortality, is one of the major global health challenges of the 21st century. It significantly increases the risk of type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and certain forms of cancer. New and emerging medicines have shown unprecedented efficacy in promoting weight loss and reducing the risk of many of these diseases.


This meeting aims to integrate existing knowledge with the latest discoveries informing the mechanisms of obesity drug action, exploring potential health benefits beyond weight loss. The program will cover new biological discoveries in the field, including those related to glucagon and amylin, and leveraging the role of enteroendocrine cell secretion. The program will also highlight cutting-edge drug discovery approaches and the clinical relevance of basic science discoveries to obesity research. We will explore how to improve the quality of weight loss, by minimizing side effects and preserving muscle mass and function, as well as advances in diverse combination therapies.


Additionally, this conference will be held jointly with the Keystone Symposium on “Cardiometabolism in Health and Disease,” to enable better understanding of the intersection of these diseases, and their treatments. This pairing provides an opportunity for cross-disciplinary insights and collaborations towards novel research directions and greater clinical impacts across both fields.

Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates